# Efficacy and Safety of Lodenafil Carbonate in the Treatment of Erectile Dysfunction in Patients With Diabetes.

> **NCT01180283** · PHASE4 · COMPLETED · sponsor: **Cristália Produtos Químicos Farmacêuticos Ltda.**

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** lodenafil carbonate

## Key facts

- **NCT ID:** NCT01180283
- **Lead sponsor:** Cristália Produtos Químicos Farmacêuticos Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** —
- **Final completion:** 2010-04
- **Target enrollment:** — (—)
- **Last updated:** 2010-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01180283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01180283, "Efficacy and Safety of Lodenafil Carbonate in the Treatment of Erectile Dysfunction in Patients With Diabetes.". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01180283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*